期刊文献+

载紫杉醇缓释微球的制备及其体外抑瘤效果的观察 被引量:2

Preparation of paclitaxel-loaded PLGA microspheres and their in vitro inhibitory effect on tumor cells
原文传递
导出
摘要 目的应用乳酸-羟基乙酸共聚物(PLGA)制备载紫杉醇(PTX)PLGA微球,探讨其理化性质及其体外抑瘤效果。方法采用双乳剂挥发法制备PTX-PLGA微球,扫描电镜及光学显微镜观察其外观形态,测定微球径线。高效液相色谱法评价PTX-PLGA微球载药率及其包封率。培养卵巢癌SKOV3细胞株,并设空白对照组、生理盐水组、PLGA微球悬液组、紫杉醇注射液组和PTX-PLGA微球悬液组,应用MTT法检测不同处理组在不同时间细胞的生长抑制情况,倒置显微镜下观察肿瘤细胞凋亡形态。结果 PTX-PLGA微球大小均匀,表面光滑无粘连,平均直径为(2.00±0.19)μm,载药率约为5.68%,包封率为81.10%。给药72 h后药物浓度为1×105mol/L时,PTX-PLGA组的卵巢癌细胞增殖明显受到抑制(P<0.05)。结论本法制备的PTX-PLGA微球性质稳定,对卵巢癌细胞的抑制作用具有一定缓释效果。 Objective To prepare poly(lactic-co-glycolic acid)(PLGA)microspheres containing paclitaxel(PTX),and to evaluate their physicochemical properties and in vitro inhibitory effect on tumor cells.Methods PLGA microspheres containing PTX were prepared by the double emulsion evaporation method.The morphology and grain diameters of microspheres were observed by a scanning electron microscope(SEM)and an optical microscope.HPLC was used to detect the drug loading amount and encapsulation efficiency.Cultured cells of the human ovarian carcinoma cell line SKOV3 were treated with RPMI1640 as blank controls,normal saline(NS),PLGA,PTX and PTX-PLGA microspheres.The proliferation of SKOV3 cells was determined by MTT assay and the morphological change was observed under an inverted microscope.Results The microspheres with a mean particle size of(2.00±0.19)μm were uniform and smooth.Drug loading amount and encapsulation efficiency were 5.68% and 81.10%,respectively.Proliferation of SKOV3 cells was significantly inhibited by PTX-PLGA microspheres at 1×105mol/L in 72 h(P0.05).Conclusion PTX-PLGA microspheres prepared by this method are stable and have sustained release effect on inhibiting proliferation of SKOV3 cells in vitro.
出处 《山东大学学报(医学版)》 CAS 北大核心 2011年第12期39-41,47,共4页 Journal of Shandong University:Health Sciences
基金 山东省科技发展计划资助项目(2005GG3202191)
关键词 乳酸-羟基乙酸共聚物 微球 紫杉醇 卵巢肿瘤 Poly(lactic-co-glycolic acid) Microsphere Paclitaxel Ovarian neoplasms
  • 相关文献

参考文献11

二级参考文献54

共引文献46

同被引文献19

  • 1冉海涛,任红,王志刚,郑元义,张群霞,李小东,许川山.一种新型高分子聚合材料微泡超声造影剂的制备与体外显影实验[J].中华超声影像学杂志,2005,14(10):774-776. 被引量:26
  • 2余志英,李丽文,杜静,夏俊霞,罗军,骆琦.紫杉醇诱导卵巢癌细胞凋亡及细胞周期改变的研究[J].中国医师杂志,2006,8(3):322-324. 被引量:5
  • 3王美清.紫杉醇的临床毒副作用分析及对策[J].中国热带医学,2007,7(2):237-237. 被引量:7
  • 4Vaughn D J, Brown A W Jr, Harker W G, et al. Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma[J]. Cancer, 2004, 100(4):746-750.
  • 5Weissleder R. Molecular imaging in cancer[J]. Science, 2006, 312(5777) :1168-1171.
  • 6Markman M. Weekly paclitaxel in the management of ovarian cancer [J]. Semin Oncol, 2000, 27 ( 3Suppl 7 ) : 37-40.
  • 7Shen G, Huang H, Zhang A, et al. In vivo activity of anti-ErbB2 antibody chA21 alone and with Paclitaxel or Trastuzumab in breast and ovarian caner xenograft models [J]. Cancer Immunol Immunother, 2011, 60 (3) : 339- 348.
  • 8Gelderblom H, Verweij J, Nooter K, et al. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation[J]. Eur J Caner, 2001, 37 (13) : 1590- 1598.
  • 9Orr G A, Verdier-Pinard P, McDaid H, et al. Mechanisms of Taxol resistance related to microtubules [ J ]. Oncongene, 2003, 22 (47) :7280-7295.
  • 10Schrader C, Keussen C, Bewig B, et al. Symptoms and signs ofan acute myocardial ischemia caused by chemotherapy with Paclitaxel(Taxol) in a patient with metastatic ovarian carcinoma[J]. Eur J Meal Res, 2005, 10( 11 ): 498-501.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部